Tyra Biosciences, Inc. Share Price
NASDAQ: TYRA | Small CapTyra Biosciences, Inc. Stock Performance
Open $26.27 | Prev. Close $26.54 | Circuit Range N/A |
Day Range $26.02 - $26.50 | Year Range $9.99 - $40.42 | Volume 23,767 |
Average Traded $26.18 |
Tyra Biosciences, Inc. Share Price Today
As of 11 August 2026, Tyra Biosciences, Inc.'s share price is $26.23. The stock opened at $26.27, compared to its previous close of $26.54. During today's trading session, Tyra Biosciences, Inc.'s share price traded between $26.02 and $26.50, with an average price of $26.26. Over the past 52 weeks, the stock has recorded a high of $40.42 and a low of $9.99. In terms of performance, Tyra Biosciences, Inc.'s share price has declined by 21.34% over the last six months and is up 107.72% on a year-on-year basis.
Tyra Biosciences, Inc. Share Price Chart
Tyra Biosciences, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.56B | PE Ratio (TTM) -13.05 | Dividend Yield N/A |
EPS (TTM) $-2.01 | Revenue (TTM) N/A | Return On Equity (TTM) -46.28% |
Profit Margin N/A | Debt to Equity 0.07 | Quarterly Earnings Growth YoY -24.37% |
Tyra Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
Tyra Biosciences, Inc. Annual Profit & Loss
All figures in USD
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Tyra Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $30.84 | $26.45 | -17.14% |
Jul 2026 | $32.09 | $31.92 | -0.09% |
Jun 2026 | $32.50 | $31.95 | -4.43% |
May 2026 | $35.38 | $33.43 | -3.70% |
Apr 2026 | $39.45 | $34.72 | -9.38% |
Mar 2026 | $32.65 | $38.31 | +14.91% |
Feb 2026 | $30.68 | $33.34 | +7.88% |
Jan 2026 | $26.20 | $30.91 | +17.78% |
Dec 2025 | $21.82 | $26.24 | +16.34% |
Nov 2025 | $15.58 | $22.55 | +42.57% |
Oct 2025 | $14.12 | $15.82 | +13.24% |
Sep 2025 | $12.64 | $13.97 | +10.65% |
TYRA Share Price FAQs
What is Tyra Biosciences, Inc. share price today?
What is the 52 week high and 52 week low of Tyra Biosciences, Inc. stock?
What is TYRA's market capitalisation today?
What is TYRA's net income for the last quarter?
What is the 5 year returns of TYRA?
What is the high & low stock price of TYRA today?
Can I buy TYRA shares in India?